I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Kidney Disease and Your Vision: Understanding the Renal-Retinal Connection
How Kidney Disease Affects the Retina
Kidney disease does not stay limited to the kidneys. The systemic changes it causes can damage blood vessels throughout the body, including those inside your eyes.
The kidneys and the retina share a remarkably similar type of small blood vessel architecture. Both organs contain networks of tiny arterioles and capillaries that are especially sensitive to high blood pressure, elevated blood sugar, and circulating toxins. When systemic disease damages the blood vessels in the kidneys, the same process is typically affecting the blood vessels in the retina at the same time.
This parallel vulnerability is called the renal-retinal connection. It explains why retinal examination can offer important clues about a patient's kidney health, and why retina specialists and kidney doctors (nephrologists) often work together when monitoring patients with CKD.
Hypertensive retinopathy is retinal damage caused by sustained high blood pressure. High blood pressure is both a leading cause and a common consequence of chronic kidney disease, making it the primary driver of retinal changes in CKD patients.
Over time, elevated blood pressure causes the walls of retinal arterioles (the smallest arteries supplying the retina) to thicken and narrow. As the damage progresses, retinal hemorrhages (small areas of bleeding), cotton-wool spots (patches of swollen nerve fibers), hard exudates (fatty deposits), and in severe cases, disc swelling may develop. The severity of these findings generally reflects how poorly blood pressure has been controlled and how advanced the underlying kidney disease has become.
As kidney function declines, waste products that healthy kidneys would normally filter out begin to accumulate in the bloodstream. These are called uremic toxins. They directly damage the cells lining blood vessel walls throughout the body, including within the retina.
Uremia also contributes to chronic inflammation and oxidative stress, both of which accelerate microvascular damage. Even patients without diabetes can develop significant retinal changes when uremia is combined with poorly controlled blood pressure and CKD-related anemia.
OCT angiography (a non-invasive imaging technique that maps retinal blood vessels without the use of injected dye) has revealed that patients with CKD have measurably lower retinal vascular density compared to healthy individuals. In simpler terms, the network of tiny blood vessels in the retina becomes less dense as kidney disease progresses.
These changes can often be detected before visual symptoms appear, which is one reason regular retinal imaging serves as an early indicator of systemic microvascular disease progression.
The choroid is the vascular layer that sits just beneath the retina and provides much of its blood supply. As CKD advances, both the choroid and the retinal nerve fiber layer (the innermost layer of the retina, composed of nerve tissue) tend to become thinner.
This thinning has been documented in patients across multiple CKD stages, including those on dialysis. Importantly, research suggests these structural changes may be partially reversible with effective treatment, giving further reason to manage systemic risk factors proactively rather than waiting for symptoms to develop.
Who Is Most at Risk
Chronic kidney disease affects a large segment of the adult population, but certain individuals face a considerably higher risk of developing retinal complications. Knowing your risk factors helps you and your care team prioritize appropriate monitoring and early intervention.
Retinal complications from CKD are most common and most pronounced in patients with advanced kidney disease, particularly those in the later stages or receiving dialysis. Older adults are more likely to have both CKD and retinal disease simultaneously, and the presence of diabetes or hypertension significantly amplifies the risk associated with either condition alone.
All patients with CKD, regardless of stage, should be aware that their eyes may be affected and should include regular eye examinations as part of their overall care plan.
Among patients with CKD, several factors raise the risk of retinal damage even further.
- Uncontrolled high blood pressure is the single strongest modifiable risk factor for retinal damage in CKD
- Diabetes adds diabetic retinopathy to the existing hypertensive and uremic retinal risks
- Protein in the urine (proteinuria or albuminuria) is associated with more severe retinal microvascular changes
- Anemia from CKD reduces oxygen delivery to the retina and can contribute to retinal hemorrhages
- Smoking, cardiovascular disease, and elevated cholesterol further increase the risk of retinal vascular complications
Managing each of these factors, not just kidney disease in isolation, is essential to protecting your retinal health over time.
Symptoms and Examination Findings
Retinal changes from kidney disease can be present long before any symptoms develop. Recognizing the warning signs and understanding what an eye examination looks for gives patients a stronger foundation for participating in their own care.
In the early stages, many patients have no visual symptoms at all even with documented retinal changes on imaging. As disease progresses, symptoms may begin to appear.
- Blurred vision from hypertensive retinopathy or macular edema (swelling in the central portion of the retina)
- Sudden vision loss from retinal vein or artery occlusion (a blockage in a retinal blood vessel)
- New floaters from vitreous hemorrhage (bleeding into the gel-filled space inside the eye)
- Gradual decline in visual clarity from cumulative retinal damage
Some patients also notice transient (temporary) vision changes during or shortly after dialysis sessions. This can occur because the fluid and pressure shifts associated with dialysis can temporarily affect the retina and choroid.
During a dilated retinal examination, our specialists look for specific signs that reflect the state of your retinal vascular health. These include narrowing of retinal arterioles, arteriovenous nicking (where arteries compress veins at crossing points), retinal hemorrhages, cotton-wool spots, hard exudates, and in more advanced disease, swelling of the optic disc.
With advanced imaging tools like OCT and OCT angiography, we can also detect and measure retinal and choroidal thinning and reduced capillary density before these changes are visible to the naked eye. The combination of clinical examination and detailed imaging gives us a comprehensive picture of how kidney disease is affecting your retinal health.
Diagnosis and Monitoring
An accurate diagnosis requires both a thorough clinical examination and specialized retinal imaging. We use several complementary tools to assess the extent of retinal changes and track them systematically over time.
A dilated fundus examination is the foundation of retinal evaluation. Eye drops are used to widen the pupils, allowing our specialists to directly examine the retinal blood vessels, the optic disc, and surrounding tissue. Retinal findings are characterized based on severity, from mild arteriolar narrowing to advanced changes involving hemorrhages, exudates, and disc swelling.
This examination not only reveals the condition of the retina but also provides valuable information about overall vascular health. The retina is the only location in the body where blood vessels can be viewed directly and non-invasively, making it a unique window into systemic microvascular disease.
Optical coherence tomography (OCT) uses light waves to create detailed, cross-sectional images of the retinal layers. It allows us to measure the thickness of the retinal nerve fiber layer and the choroid with high precision, detecting thinning that may not be visible on clinical examination alone.
OCT angiography builds on this technology to produce detailed maps of the retinal and choroidal capillary networks. By identifying areas of reduced vascular density or capillary dropout (areas where small blood vessels have been lost), we can detect early microvascular damage and monitor changes over time. Serial imaging, meaning repeated measurements at scheduled intervals, is one of the most valuable tools available for tracking CKD-related retinal changes.
Retinal findings are most meaningful when interpreted alongside your kidney function results, including estimated glomerular filtration rate (eGFR, a measure of how well the kidneys are filtering the blood), urine albumin levels, and blood pressure readings. Our team coordinates regularly with referring nephrologists and primary care providers to correlate retinal changes with kidney disease staging.
When retinal findings worsen, this can be a signal that systemic disease management needs to be intensified. Sharing imaging data and examination findings across your care team helps everyone make better-informed decisions about your overall health.
Treatment Approaches
Treatment for CKD-related retinal changes focuses primarily on controlling the systemic conditions driving the damage. In some cases, targeted retinal treatments are also used to address specific complications as they arise.
Sustained, well-controlled blood pressure is the single most important factor in protecting both the kidneys and the retina in patients with CKD. Certain blood pressure-lowering medications, particularly ACE inhibitors and angiotensin receptor blockers (ARBs), offer dual benefits for kidney and vascular protection. Consistent blood pressure control slows the progression of hypertensive retinopathy and reduces the risk of retinal vascular events.
Your nephrologist and primary care provider work together to optimize your blood pressure regimen. Our specialists communicate with your medical team to ensure that retinal findings are factored into those decisions when relevant.
For patients with diabetic kidney disease, keeping blood sugar well controlled is essential for slowing the progression of both diabetic retinopathy and diabetic nephropathy (kidney damage caused by diabetes). Treatment of CKD-related anemia with medications that stimulate red blood cell production, along with iron supplementation, improves oxygen delivery to the retina and may reduce anemia-related hemorrhages.
Managing cholesterol and other lipid abnormalities, along with smoking cessation, further reduces vascular risk throughout the body including in the retina. Addressing each contributing factor in a coordinated way is part of a comprehensive management approach.
When specific retinal complications develop, targeted treatments are available. Anti-VEGF injections (medications that reduce abnormal blood vessel growth and fluid leakage) are used to treat macular edema when it develops in CKD patients. Laser photocoagulation may be needed if retinal ischemia (inadequate blood supply to retinal tissue) leads to abnormal new vessel growth. Retinal vein or artery occlusions are managed with monitoring and intervention guided by the clinical situation.
Our retina specialists coordinate these treatments as part of your broader management plan, adjusting the approach based on how your retina responds over time.
Patients on dialysis may notice transient vision changes during or after treatment sessions due to the fluid and electrolyte shifts that occur. OCT imaging has documented measurable changes in choroidal thickness during dialysis. These effects are usually temporary, but any visual changes during or after dialysis should be reported to both your dialysis team and your eye care provider so they can be assessed appropriately.
Kidney transplantation, when clinically appropriate, may help stabilize retinal changes by restoring kidney function and reducing the uremic burden on retinal blood vessels.
Living With CKD and Retinal Changes
Managing the eye effects of kidney disease is a long-term commitment that involves multiple providers working together. A coordinated approach helps ensure that changes in your kidney health and your retinal health are addressed as part of a unified care plan.
When blood pressure and other risk factors are well controlled, the progression of CKD-related retinal changes can often be meaningfully slowed. Mild hypertensive retinopathy may stabilize and in some cases partially improve with effective blood pressure treatment. More advanced changes such as hemorrhages and hard exudates may take several months to clear after systemic control is achieved.
Regular retinal monitoring allows us to recognize and respond to new developments early, before they threaten significant vision. Patients who stay engaged with their care and attend scheduled follow-up appointments tend to have the best long-term outcomes.
Effective management of CKD-related retinal changes requires close communication among your retina specialist, nephrologist, and primary care provider. Your nephrologist oversees kidney disease treatment and dialysis management. Your retina specialist monitors retinal health and treats any ocular complications that develop. Your primary care provider helps manage blood pressure, blood sugar, and other systemic risk factors that affect both organs.
Sharing test results, imaging data, and treatment decisions across all members of your care team supports a comprehensive and consistent approach to your overall health.
Consistent adherence to your prescribed medications is one of the most impactful daily steps you can take for your retinal health. Monitoring blood pressure at home, following your kidney-friendly diet, attending all scheduled medical appointments, and avoiding smoking all contribute directly to slowing retinal damage.
These daily habits do not replace regular eye examinations, but they create the systemic foundation that makes all other treatments more effective over time.
When to See a Retina Specialist
Knowing when to seek prompt evaluation can make a meaningful difference in preserving your vision. Some symptoms require same-day or urgent attention rather than a routine appointment.
Contact your eye care provider right away if you experience any of the following.
- Sudden loss of vision in one or both eyes
- A new curtain, shadow, or dark area across your field of vision
- A sudden increase in floaters or new flashing lights
- Rapidly developing blur or distortion in your central vision
These symptoms in a patient with CKD may indicate a retinal vascular occlusion, vitreous hemorrhage, or retinal detachment, all of which require prompt evaluation and possible treatment. Vision changes during or after dialysis should also be reported to your care team rather than assumed to be temporary and inconsequential.
If your general ophthalmologist or optometrist identifies significant retinal changes during a routine examination, referral to a retina specialist provides access to specialized imaging, diagnostic interpretation, and targeted treatment options. Advanced hypertensive retinopathy, macular edema, retinal vascular occlusions, and other posterior segment findings benefit from the focused expertise that a retina specialist can provide.
We accept both referred patients and those who contact us directly. Prompt evaluation allows us to establish a baseline and monitor your retinal health alongside your ongoing kidney care.
Frequently Asked Questions
Patients and their families often have practical questions about how kidney disease connects to eye health. These answers are intended to guide decision-making and clarify what to expect in different situations.
Yes, and this is one of the most important points for CKD patients to understand. Many of the most significant retinal changes from kidney disease develop before any visual symptoms appear. OCT imaging can detect retinal and choroidal thinning, and OCT angiography can reveal reduced capillary density, long before a patient notices anything wrong. Waiting for symptoms means allowing the disease to advance further than necessary before acting. Regular examinations allow us to detect and monitor changes early, when management options are broadest.
The appropriate frequency depends on several individual factors, including your current CKD stage, how well your blood pressure and blood sugar are controlled, whether you have diabetes, and the severity of any existing retinal findings. Patients with advanced CKD, those receiving dialysis, or those with documented retinal changes will typically need more frequent monitoring than patients in earlier stages with well-controlled risk factors. Your retina specialist and nephrologist will recommend a schedule tailored to your clinical situation, and that schedule may be adjusted as your condition changes over time.
Dialysis itself is not a direct cause of retinal damage, but the fluid and electrolyte shifts that occur during each session can temporarily affect choroidal thickness and retinal perfusion. Most patients tolerate this without lasting effects, but some notice brief blurring or other transient visual changes during or shortly after treatment. These should be mentioned to your dialysis team and your eye care provider rather than dismissed. Persistent or worsening vision changes around dialysis sessions warrant formal evaluation, as they could reflect an underlying issue that needs attention.
Successful kidney transplantation can help stabilize retinal changes by restoring kidney function and reducing the accumulation of uremic toxins. Whether existing retinal changes improve after transplant depends largely on how advanced they were at the time of surgery and how effectively systemic factors like blood pressure are managed afterward. Transplantation may slow further progression and reduce the risk of new complications developing, but it is not guaranteed to reverse damage that is already established. Close retinal monitoring should continue after transplantation.
They overlap but are not identical. Diabetic retinopathy results specifically from blood sugar-related damage to retinal blood vessels, causing a distinct pattern of changes including microaneurysms (tiny balloon-like bulges in vessel walls) and abnormal new vessel growth. CKD-related retinal changes are primarily driven by high blood pressure and uremic toxins, producing hypertensive retinopathy with arteriolar narrowing, hemorrhages, and exudates. Patients who have both diabetes and CKD experience both types of damage simultaneously, which is why a thorough evaluation with imaging is important for accurately characterizing what is happening in each patient's retina and guiding the right treatment approach.
Expert Retinal Care for Kidney Disease Patients
At New England Retina Associates, our fellowship-trained vitreoretinal specialists have extensive experience evaluating and managing retinal changes associated with kidney disease, hypertension, and other systemic conditions. We work closely with referring nephrologists and primary care providers to ensure your retinal health is monitored as part of your comprehensive care plan. Patients throughout Connecticut are welcome to contact any of our offices for a referral appointment or to schedule a direct evaluation. Early assessment gives us the best opportunity to protect your vision for the long term.
30 Years of Care & Commitment
